TherapeuticsMD (TXMD) Asset Utilization Ratio (2011 - 2026)

TherapeuticsMD has reported Asset Utilization Ratio for 15 years, with the latest figure at 0.09 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 86.54% year-over-year to 0.09; the trailing twelve-month figure through Mar 2026 stood at 0.09 (up 86.54% YoY), and the FY2025 full-year result was 0.08, up 84.29% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.09, up from 0.08 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 1.33 in Q3 2023, with the low at 0.03 in Q2 2024.
• Historically, Asset Utilization Ratio has averaged 0.33 across 5 years, with a median of 0.08 in 2025.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio surged 830.44% — and 2024, when it plunged 97.82%.
• TherapeuticsMD's Asset Utilization Ratio stood at 0.62 in 2022, then sank by 95.19% to 0.03 in 2023, then surged by 49.69% to 0.04 in 2024, then soared by 76.21% to 0.08 in 2025, then rose by 12.56% to 0.09 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.09 (Q1 2026), 0.08 (Q4 2025), and 0.07 (Q3 2025), per Business Quant data.